Related Experiment Video
Updated: Jul 15, 2026

High Throughput SiRNA Screening for Chloropicrin and Hydrogen Fluoride-Induced Cornea Epithelial Cell Injury
Published on: June 16, 2018
Investigation of accidental secondary exposure to CS agent
Steven M Hankin1, Colin N Ramsay
1Health Protection Scotland, Clifton House, Clifton Place, Glasgow, UK. Steve.Hankin@hps.scot.nhs.uk
Abstract:
We report on an unusual exposure to o-chlorobenzylidene malononitrile (CS agent) following its use to detect unauthorized stowaways aboard a vehicle, and the subsequent handling of the cargo delivered to retail stores across Scotland. Twenty-one staff in 16 retail stores across Scotland experienced symptoms including itching and running eyes, rhinorhoea, a burning sensation on the face and hands, and a burning throat, following the furniture deliveries. A survey was conducted to assess the extent of exposure to the contaminated furniture and the scale of illness associated with exposure. Experiencing symptoms was significantly associated with having contact with the furniture or packaging (chi(2) = 10.5, p < 0.001). This incident demonstrates the risk of inadvertent secondary exposure and subsequent acute symptoms from contact with residual CS agent when sprayed in the confined spaces of haulage vehicles.
Related Concept Videos
Pharmaceutical Poisoning: Potential Scenarios
Prevention of Further Absorption of Poison
Toxic Reactions: Overview
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Drug Toxicity: Allergic Reactions
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...

